Sana Biotechnology Inc (SANA)
2.61
+0.26
(+11.06%)
USD |
NASDAQ |
Nov 22, 16:00
2.68
+0.07
(+2.68%)
After-Hours: 20:00
Sana Biotechnology Market Cap: 582.73M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 582.73M |
| November 21, 2024 | 524.68M |
| November 20, 2024 | 564.87M |
| November 19, 2024 | 526.91M |
| November 18, 2024 | 522.45M |
| November 15, 2024 | 540.31M |
| November 14, 2024 | 578.27M |
| November 13, 2024 | 593.90M |
| November 12, 2024 | 634.08M |
| November 11, 2024 | 645.25M |
| November 08, 2024 | 670.92M |
| November 07, 2024 | 692.13M |
| November 06, 2024 | 761.35M |
| November 05, 2024 | 756.88M |
| November 04, 2024 | 839.49M |
| November 01, 2024 | 817.16M |
| October 31, 2024 | 781.44M |
| October 30, 2024 | 816.58M |
| October 29, 2024 | 843.35M |
| October 28, 2024 | 874.58M |
| October 25, 2024 | 838.89M |
| October 24, 2024 | 850.04M |
| October 23, 2024 | 845.58M |
| October 22, 2024 | 870.12M |
| October 21, 2024 | 876.81M |
| Date | Value |
|---|---|
| October 18, 2024 | 943.75M |
| October 17, 2024 | 905.82M |
| October 16, 2024 | 943.75M |
| October 15, 2024 | 923.67M |
| October 14, 2024 | 894.66M |
| October 11, 2024 | 890.20M |
| October 10, 2024 | 854.50M |
| October 09, 2024 | 890.20M |
| October 08, 2024 | 910.28M |
| October 07, 2024 | 939.28M |
| October 04, 2024 | 943.75M |
| October 03, 2024 | 948.21M |
| October 02, 2024 | 972.75M |
| October 01, 2024 | 945.98M |
| September 30, 2024 | 928.13M |
| September 27, 2024 | 952.15M |
| September 26, 2024 | 949.93M |
| September 25, 2024 | 836.47M |
| September 24, 2024 | 909.89M |
| September 23, 2024 | 909.89M |
| September 20, 2024 | 945.48M |
| September 19, 2024 | 1.028B |
| September 18, 2024 | 954.38M |
| September 17, 2024 | 956.60M |
| September 16, 2024 | 969.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
522.45M
Minimum
Nov 18 2024
8.149B
Maximum
Feb 10 2021
1.917B
Average
1.241B
Median
May 11 2023
Market Cap Benchmarks
| Foghorn Therapeutics Inc | 435.85M |
| Omega Therapeutics Inc | 43.52M |
| Moderna Inc | 15.82B |
| Summit Therapeutics Inc | 14.01B |
| Apellis Pharmaceuticals Inc | 3.828B |
Market Cap Related Metrics
| Price to Book Value | 1.992 |
| Price | 2.61 |
| Earnings Yield | -53.64% |